
Allison M. Fox
Examiner (ID: 18391, Phone: (571)272-2936 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653, 1651, 1633 |
| Total Applications | 1151 |
| Issued Applications | 659 |
| Pending Applications | 119 |
| Abandoned Applications | 390 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15797171
[patent_doc_number] => 20200121728
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields
[patent_app_type] => utility
[patent_app_number] => 16/661889
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661889 | Prevention and Treatment of Teratoma Formation in Stem Cell-Based Therapies Using Alternating Electric Fields | Oct 22, 2019 | Pending |
Array
(
[id] => 15650337
[patent_doc_number] => 20200087698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => METHODS FOR INCREASING MANNOSE CONTENT OF RECOMBINANT PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/654933
[patent_app_country] => US
[patent_app_date] => 2019-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11889
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16654933
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/654933 | Methods for increasing mannose content of recombinant proteins | Oct 15, 2019 | Issued |
Array
(
[id] => 17226331
[patent_doc_number] => 20210352887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => OXYGENATION MEDIA FOR EX-VIVO PRESERVATION OF ORGANS AND TISSUES
[patent_app_type] => utility
[patent_app_number] => 17/284668
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284668
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284668 | OXYGENATION MEDIA FOR EX-VIVO PRESERVATION OF ORGANS AND TISSUES | Oct 10, 2019 | Pending |
Array
(
[id] => 15766051
[patent_doc_number] => 20200114043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => DECELLULARIZED MUSCLE MATRIX
[patent_app_type] => utility
[patent_app_number] => 16/598597
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9274
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16598597
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/598597 | DECELLULARIZED MUSCLE MATRIX | Oct 9, 2019 | Abandoned |
Array
(
[id] => 16998364
[patent_doc_number] => 11077146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-03
[patent_title] => Method for treating diabetes and other glucose regulation disorders using stem cells
[patent_app_type] => utility
[patent_app_number] => 16/555987
[patent_app_country] => US
[patent_app_date] => 2019-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3172
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16555987
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/555987 | Method for treating diabetes and other glucose regulation disorders using stem cells | Aug 28, 2019 | Issued |
Array
(
[id] => 17785775
[patent_doc_number] => 11408893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Selective near-infrared optical imaging of necrotic cells and simultaneous cell fixing and counter staining with metallacrown complexes
[patent_app_type] => utility
[patent_app_number] => 16/547396
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 31
[patent_no_of_words] => 12738
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16547396
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/547396 | Selective near-infrared optical imaging of necrotic cells and simultaneous cell fixing and counter staining with metallacrown complexes | Aug 20, 2019 | Issued |
Array
(
[id] => 20491030
[patent_doc_number] => 12532880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Cryopreservation of cell monolayers
[patent_app_type] => utility
[patent_app_number] => 17/269987
[patent_app_country] => US
[patent_app_date] => 2019-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 13601
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269987
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269987 | Cryopreservation of cell monolayers | Aug 20, 2019 | Issued |
Array
(
[id] => 19792239
[patent_doc_number] => 12233162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-25
[patent_title] => Method for preparing liposomes
[patent_app_type] => utility
[patent_app_number] => 17/266904
[patent_app_country] => US
[patent_app_date] => 2019-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14353
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266904 | Method for preparing liposomes | Aug 8, 2019 | Issued |
Array
(
[id] => 15145013
[patent_doc_number] => 20190350984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => FROZEN THERAPEUTIC DOSE AND PACKAGE
[patent_app_type] => utility
[patent_app_number] => 16/525062
[patent_app_country] => US
[patent_app_date] => 2019-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4760
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16525062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/525062 | FROZEN THERAPEUTIC DOSE AND PACKAGE | Jul 28, 2019 | Abandoned |
Array
(
[id] => 17635173
[patent_doc_number] => 11345889
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Three dimensional heterogeneously differentiated tissue culture
[patent_app_type] => utility
[patent_app_number] => 16/520020
[patent_app_country] => US
[patent_app_date] => 2019-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 15626
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16520020
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/520020 | Three dimensional heterogeneously differentiated tissue culture | Jul 22, 2019 | Issued |
| 16/513183 | METHODS FOR MAKING ACELLULAR TISSUE MATRICES | Jul 15, 2019 | Abandoned |
Array
(
[id] => 17981207
[patent_doc_number] => 20220347243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS FOR TREATING TUMORS
[patent_app_type] => utility
[patent_app_number] => 17/622217
[patent_app_country] => US
[patent_app_date] => 2019-07-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9942
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622217
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622217 | PHARMACEUTICAL COMPOSITIONS, KITS AND METHODS FOR TREATING TUMORS | Jul 3, 2019 | Abandoned |
Array
(
[id] => 17874343
[patent_doc_number] => 11446335
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Cryopreserved endocrine cells that express chromogranin A
[patent_app_type] => utility
[patent_app_number] => 16/452415
[patent_app_country] => US
[patent_app_date] => 2019-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 83
[patent_figures_cnt] => 136
[patent_no_of_words] => 63001
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16452415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/452415 | Cryopreserved endocrine cells that express chromogranin A | Jun 24, 2019 | Issued |
Array
(
[id] => 15708699
[patent_doc_number] => 20200101115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/449867
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13963
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16449867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/449867 | BONE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF | Jun 23, 2019 | Abandoned |
Array
(
[id] => 15206529
[patent_doc_number] => 20190365951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => HUMAN CARDIAC TISSUE CONSTRUCT, RELATED METHODS AND USES
[patent_app_type] => utility
[patent_app_number] => 16/431593
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17180
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16431593
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/431593 | HUMAN CARDIAC TISSUE CONSTRUCT, RELATED METHODS AND USES | Jun 3, 2019 | Abandoned |
Array
(
[id] => 14868573
[patent_doc_number] => 20190284528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => METHOD FOR INDUCING OLIGODENDROCYTE PRECURSOR CELLS FROM OCT4-INDUCED HUMAN SOMATIC CELLS THROUGH DIRECT REPROGRAMMING
[patent_app_type] => utility
[patent_app_number] => 16/429062
[patent_app_country] => US
[patent_app_date] => 2019-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6148
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16429062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/429062 | Method for inducing oligodendrocyte precursor cells from Oct4-induced human somatic cells through direct reprogramming | Jun 2, 2019 | Issued |
Array
(
[id] => 15114515
[patent_doc_number] => 20190343890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-14
[patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING THE PROLIFERATION AND EPITHELIAL-MESENCHYMAL TRANSITION OF EPITHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 16/421191
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31608
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16421191
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/421191 | Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells | May 22, 2019 | Issued |
Array
(
[id] => 18245986
[patent_doc_number] => 11602549
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-14
[patent_title] => Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 16/421086
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12603
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16421086
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/421086 | Laminated tissue grafts composed of Wharton's jelly and methods of making and using the same | May 22, 2019 | Issued |
Array
(
[id] => 16822697
[patent_doc_number] => 20210137990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => METHODS FOR EXP ANDING ADIPOSE-DERIVED STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/053200
[patent_app_country] => US
[patent_app_date] => 2019-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9934
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053200
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053200 | METHODS FOR EXP ANDING ADIPOSE-DERIVED STEM CELLS | May 6, 2019 | Abandoned |
Array
(
[id] => 16992131
[patent_doc_number] => 20210230551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION
[patent_app_type] => utility
[patent_app_number] => 17/052854
[patent_app_country] => US
[patent_app_date] => 2019-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12821
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052854
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052854 | ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION | May 2, 2019 | Abandoned |